Yuerong Hu

Title: Yuerong Hu: Innovator in Pharmaceutical Crystallography

Introduction

Yuerong Hu is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of pharmaceutical crystallography, particularly in the development of various forms of cis-FTC, which are crucial in the treatment of viral infections such as HIV and hepatitis B. With a total of 3 patents, his work has garnered attention in the scientific community.

Latest Patents

Yuerong Hu's latest patents focus on the polymorphic and crystalline forms of cis-FTC. These patents describe solid phases of (−)-cis-FTC, including amorphous (−)-FTC and Forms II and III of (−)-cis-FTC. These forms can be distinguished from Form I (−)-cis-FTC through X-ray powder diffraction patterns, thermal properties, and methods of manufacture. Additionally, he has developed a hydrated crystalline form of (±)-cis-FTC, as well as a dehydrated form of the hydrate. These forms can also be differentiated from other FTC forms by similar methods. The applications of these FTC forms extend to the manufacture of pharmaceutical compositions, particularly for treating HIV or hepatitis B.

Career Highlights

Throughout his career, Yuerong Hu has worked with prominent companies in the pharmaceutical industry, including Gilead Sciences, Inc. His expertise in crystallography and pharmaceutical formulations has positioned him as a valuable asset in the development of innovative treatments.

Collaborations

Yuerong Hu has collaborated with notable professionals in his field, including Devalina Law and Kenneth R Phares. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Yuerong Hu's contributions to the field of pharmaceutical crystallography and his innovative patents have made a significant impact on the treatment of viral infections. His work continues to influence the development of effective pharmaceutical compositions.